Sort
23,748 grants matching “melanoma”
Validation of Genomic Targets in Melanoma
$370,543Mohammed Kashani-Sabet · California Pacific Med Ctr Res Institute · R01 · FY2011 · CA
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
$370,513Victor H. Engelhard · University Of Virginia · R01 · FY2008 · AI
Targeted therapies in cutaneous melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2020 · CA
Cancer prevention and treatment by activation of a brain-adipocyte axis
$370,500Lei Cao · Ohio State University · R01 · FY2021 · CA
Targeted therapies in cutaneous melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2021 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2020 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$370,500Roger S Lo · University Of California Los Angeles · R01 · FY2020 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$370,500Roger S Lo · University Of California Los Angeles · R01 · FY2021 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$370,500Roger S Lo · University Of California Los Angeles · R01 · FY2019 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2018 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2021 · CA
Cancer prevention and treatment by activation of a brain-adipocyte axis
$370,500Lei Cao · Ohio State University · R01 · FY2020 · CA
Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral Nerves
$370,450Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
Investigating p16 Loss in Pro-tumorigenic Metabolism
$370,446Katherine Marie Aird · Pennsylvania State Univ Hershey Med Ctr · R37 · FY2020 · CA
The B7x pathways in the tumor microenvironment
$370,440Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
$370,439Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2023 · CA
Mechanisms of UVA-induced skin cancer
$370,324Yu-Ying He · University Of Chicago · R01 · FY2013 · ES
PDK1 as a Novel Target in Melanoma
$370,276Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors
$370,260Gelareh Zadeh · University Health Network · R01 · FY2024 · CA
Uncover the new subsets of epidermal Langerhans cells
$370,230Qing-Sheng Mi · Henry Ford Health System · R61 · FY2020 · AR
Novel Biosynthetic Pathway for Secosteroids and the Skin
$370,153Andrzej T Slominski · University Of Tennessee Health Sci Ctr · R01 · FY2009 · AR
Type I Interferon Responses in the Pathobiology of Anthracycline-induced Cardiotoxicity
$370,136Andrew Phillip West · Jackson Laboratory · R01 · FY2023 · HL
Biobehavioral Role of Brain Kynurenine Metabolism in Mental Illness
$370,013Jason C O'Connor · University Of Texas Hlth Science Center · R01 · FY2014 · MH
Targeting lymph node metastases to prevent cancer progression
$370,003Timothy P Padera · Massachusetts General Hospital · R01 · FY2019 · CA
Design and Analysis of Multi-Staged Association Studies Using Pooled Genomic DNA
$370,000Dietrich A Stephan · Translational Genomics Research Inst · U01 · FY2006 · HL